30 States Have Laws Requiring Children to Repay Medicaid for Parents Care

 

filial-states-map

Filial responsibility laws date back to 17th century English law requiring children to financially support their parents when they couldn’t support themselves.

Because of age, or maybe an illness like Alzheimer’s, millions of Americans are no longer able to take care of themselves.

Spending one’s own money for care can wipe out a life’s savings in a short time. It could be someone in your family.

What happens when the money runs out? Out of love, you may feel a moral obligation to help. In some states, however, you may be legally responsible for paying your parents’ long-term care.

In these days of economic uncertainty it is essential that people have a sense of security in terms of their future. Long term care insurance is a way to preserve that.

Like car insurance, the prices for long term care insurance will vary by company. The premium will depend on your age, health and the benefits you want.
The LTC Partnership Program provides asset protection in most states.

Since care cost differs by type and location it is important to get the right information to make an informed decision.

Other than transferring your assets to an irrevocable trust five years before you apply for Medicaid, the only way to protect your estate from Medicaid is with a Partnership long term care policy.

 

Be Prepared: Get Long Term Care Insurance Quotes


.

.

.

.

Music can improve mood and behavior for people with dementia

People with dementia showed positive changes in mood and behavior after listening to music, according to a study from researchers at George Mason University.

A documentary titled “Alive Inside” showed individuals with moderate to late stage dementia listening to personalized music with headphones. The listeners often sang along and became more talkative, showing a great improvement in mood, and decreased agitation.

The study involved 51 adults with dementia. An individualized playlist was developed for each participant. Study researchers recorded both within-person differences and between-group differences.

Behavioral observations showed increases in joy, eye contact and movement, communicating and talking. There was less restless moving, agitation, and sleeping. Participants smiled more, and were more alert and relaxed. Sometimes they recognized the music, sang, and followed the rhythm.

Music listening can be especially beneficial when the music is connected to positive memories for the listener. The music can be used in a variety of care situations, including at home. Music can be helpful to happily occupy a dementia sufferer when a caregiver needs to attend to other duties.

The study showed that music listening is a low cost, nonpharmacological intervention that can bring positive results for people with dementia.


Be Prepared: Long Term Care Insurance Quotes – You must insure before the diagnosis.


.

.

.

.

When Will We Have an Alzheimer’s Vaccine?

Scientists are working on a vaccine to delay or reduce Alzheimer’s disease. Researchers say they are close to testing the vaccine on humans.

In spite of all the research and money spent, no reliable Alzheimer’s treatments are available yet. But researchers believe they may be able to cut down the number of Alzheimer’s sufferers half.     

At the University of Texas Southwestern Medical Center, a team of scientists has developed an experimental vaccine that is designed to reduce two proteins in the brain, beta-amyloid and tau, that are associated with Alzheimer’s Disease. Buildup of these proteins prevents the brain from functioning normally. In mice, the vaccine reduces beta-amyloid protein by up to 40 percent and tau by up to 50 percent.

If the vaccine has the same effect on humans, it could delay the onset of Alzheimer’s by five years, or cut in half the number of people affected.

The main problem with animal studies is that human diseases and immune systems don’t always work the same way. Another problem is that proteins can build up in the brain for 20 years before a patient will have symptoms. So patients would have to agree to taking the vaccine long before they know if they are susceptible to the disease. At this time, tests that show who is at risk for Alzheimer’s are expensive.

The vaccine may be tested for safety on monkeys before trying it on humans, so it will probably be 10 years or more before it is available.

At this time, around 5 million Americans have Alzheimer’s disease. The Centers for Disease Control and Prevention estimate that by 2060 there will 14 million. The National Institute of Health will spend 2.3 billion on Alzheimer’s research this year.

Read more about Alzheimer’s and Dementia: Link

Be Prepared: Get Long Term Care Insurance Quotes


.

.

.

.

Promising New Research May Lead To Reversal of Alzheimer’s Dementia

1in3&69sec

Scientists have recently discovered a possible new way to reverse Alzheimer’s disease.

A new study found that amyloid protein plaques, associated with Alzheimer’s disease, were eliminated when researchers removed a naturally occurring enzyme called BACE1 from the brains of mice.

Riqiang Yan and his team at the Cleveland Clinic studied mice that were genetically engineered to have a rodent form of Alzheimer’s disease. BACE1, known as beta-secretase, clings to the amyloid precursor protein, resulting in the production and buildup of plaques.

When the BACE1 enzyme was removed from the mouse brains, formation of amyloid plaques stopped, and plaque already in the brains of the mice disintegrated. Removal of the enzyme also improved learning and memory in the mice.

In the study, the scientists gradually removed BACE1 from the mice as they aged. By the time the mice were 10 months old (equivalent to the human age of 50 years) they no longer had any amyloid plaque in their brains.

Reducing BACE1 levels in the offspring mice also reversed other conditions found in Alzheimer’s disease, such as microglial cell activation and the formation of abnormal neuronal processes.

Yan published some of his discoveries about BACE1 in 1999 in the journal Nature. This recent study, published in the Journal of Experimental Medicine, is the first one in which researchers have seen a dramatic reversal of amyloid deposits in the brains of mice. It may lead to new therapies that could reverse Alzheimer’s disease. The next step will be to see if human brains react the same way.

Find out about the care of people with Alzheimer’s disease at the Guide To Long Term Care.

 

Be Prepared: Get Long Term Care Insurance Quotes


.

.

.

.

Nursing home patients’ response to music opens new avenues for diagnosis and therapy

A nursing home in California began playing music for residents suffering from dementia, and got responses from patients once considered unreachable.

There are thousands of nursing homes participating in an international music and memory program.

At Villa Coronado, a nursing home in San Diego, 10 residents with traumatic brain injury were given an iPod to listen to music. Over 4,500 residents in 300 California nursing homes are taking part in a statewide experiment. One of the aims of the study is to find out whether music can replace antipsychotic drugs and restraints for agitated patients. With some patients, it seems to work.

This patient population receives little or no therapy, and are mostly bedridden, isolated from the world around them. Researchers are looking to see if the music program can reduce aggressive behavior.

06_ALIVE-INSIDE_Photo-Courtesy-of-BOND360
For some people, music brings back memories. It can help dementia patients become more aware of their surroundings. Music will bring a smile to some patients, and can calm those who are agitated. Some patients listening to the music will smile, move rhythmically, and be more responsive to their loved ones.

Music is said to activate more parts of the brain than any other stimulus. New research suggests music therapy could help people in a coma or in a vegetative state.

The patients’ response to music may even help physicians to diagnose consciousness. Studies show there is a high rate of misdiagnosis in vegetative patients, where it is important to determine a patient’s chance of recovery. Observing these patients leads some workers to conclude that rather than a steady state, there is a spectrum of consciousness, and patients drift in and out.

Caroline Schnakers is an associate clinical professor in the Department of Psychiatry at UCLA. Her research indicates there is a 40 to 50 percent error rate in diagnosing a patient’s consciousness. Some patients appear to be unconscious, and yet have some signs of consciousness and awareness of their surroundings.

A patient in a minimally conscious state (MCS) is considered to have more chance to recover than a patient in a vegetative state. If a patient is observed to be sometimes conscious, there is more hope of recovery. The diagnosis of a patient determines medical treatment and end-of-life decisions, so it’s important to diagnose correctly.

Some patients thought to be in a vegetative state are actually in a minimally conscious state, and they respond to the music. One nursing home activities director was excited to see how music affected the residents, saying they just come alive.

Researchers at UC Davis plan to have the initial results of their nursing home study by the end of this year. But regardless of whether music is able to replace medication, it’s worth giving patients music to improve their quality of life.

For more information on the care of dementia patients: Alzheimer’s on Guide To Long Term Care.

Be Prepared: Get Long Term Care Insurance Quotes


.

.

.

.

Diabetes drug doing double duty as Alzheimer’s therapy

A drug developed for treating diabetes now shows promise for Alzheimer’s patients, according to scientists at England’s Lancaster University. The drug is described as a triple receptor agonist, or TA. It combines hormones glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and Glucagon, activating these three receptors at the same time. The new study is published in the journal Brain Research.

A group of mice with Alzheimer’s-related symptoms were tested in a spatial water maze. The TA drug was injected once a day for two months. The mice who were treated with the drug remembered their path better than the control group.

alz101b

In addition to the memory improvement, other symptoms were improved: the accumulation of plaque in the brain was reduced; brain nerve cells were protected from deterioration and loss; and chronic nerve inflammation was reduced, as well as oxidative stress in the cortex and hippocampus. Increased levels of synaptophysin indicated protection from synaptic loss that occurs in Alzheimer’s. An increase of doublecortin positive cells showed improved neurogenesis.

Other diabetes drugs have shown promise for Alzheimer’s patients. The two diseases are known to be related, and type 2 diabetes increases the risk of Alzheimer’s disease. Clinical trials are proceeding to investigate the neuroprotective effects of extendin-4 and liraglutide.

Alzheimer’s cases are expected to triple in the next forty years, requiring more long term care. The increase in patients will bring financial challenges as well as medical ones. For more information on supporting Alzheimer’s and dementia patients, see the Alzheimer’s Section on Guide To Long Term Care.

 

Be Prepared: Get A Long Term Care Insurance Quote


.

.

.

.

Insomnia increases Alzheimer’s risk

Just one night without enough sleep can cause harmful proteins to build up in the brain, increasing the risk of Alzheimer’s disease, according to a new study.

Past studies already linked insufficient sleep to increased risk of Alzheimer’s and other chronic diseases — but this recent study from Washington University,published in the Annals of Neurology, discovered what insomnia actually does to the brain.

1in3&69sec

One of the functions of sleep is to clear the brain of waste, including amyloid beta proteins which can bond with each other and form plaques on nerve cells. These plaques build up in the brains of people with Alzheimer’s disease.

People with a genetic tendency for Alzheimer’s disease have higher than normal levels of beta amyloid proteins, even before they develop symptoms. After a night without sleep, these higher levels appeared in the healthy study participants.

Inadequate sleep has been linked to a 1.5 fold increase in the odds of developing Alzheimer’s. It’s not surprising, therefore, that research shows that sleep disorders such as sleep apnea increase the risk.

In the study, eight participants with no previous sleep or memory problems were instructed to either stay awake all night, get a normal night’s rest, or use the drug sodium oxybate to help them sleep. The sleep aid is supposed to increase the period of deep, dreamless sleep when the brain is thought to restore itself.

The scientists tested the cerebrospinal fluid surrounding each participant’s brain for amyloid proteins. Measurements were taken before the night of the test, and then every 2 hours the next day, to show how the night of sleep or no sleep affected the accumulation of these proteins in the brain.

Study participants who went without sleep for just one night had a 25-30% increase in the beta-amyloid proteins in their cerebrospinal fluid, bringing the levels to what researchers would expect to see in people who have genes for Alzheimer’s disease. Before the test, the participants all had normal levels. The pills designed to promote the deep sleep did not affect the levels of amyloid protein.

In a healthy person, normal sleep eliminates waste and restores the brain each night. But repeated nights of insufficient rest may overwhelm the brain’s recovery system, allowing amyloid proteins to build up and form plaques which interfere with the brain’s functioning.

For information on Alzheimer’s and also long term care insurance, see Alzheimer’s Section on the Guide To Long Term Care.

 

Long Term Care Insurance Quote


.

.

.

.